Formulation and Evaluation of Capsules of Ashwagandha Phytosomes

B. Keerthi, Prasuna Sundari Pingali, Prathima Srinivas

2014 · 15 citations · 6 references

Concepts

Abstract

Objective of the present study was to formulate and evaluate capsules of Ashwagandha phytosomes. There are many herbal extracts having excellent in-vitro activity but less in-vivo activity because of their macromolecular size and poor lipid solubility, which result in poor absorption and bioavailability problems. Many of these problems can be overcome by formulating novel drug delivery systems. Phytosomes provide better absorption and bioavailability than the conventional herbal extracts. This project aims in improving the drug release characteristics of Ashwagandha by formulating Ashwagandha phytosome capsules. Ashwagandha Phytosomes were produced by a process in which standardized plant extract was bound to phospholipids, producing a lipid compatible molecular complex. Ashwagandha phytosome complexes were characterized by particle size, zeta potential, scanning electron microscopy (SEM), Fourier transform infrared spectroscopy and in vitro drug release. The results showed that the average particle size and zeta potential of optimized Ashwagandha phytosomes formulation were 98.4nm and −28.7 mV. In vitro drug release studies revealed that the cumulative % drug release of capsules of Ashwagandha phytosomes was found to be 76.8%. Antioxidant activity of Ashwagandha phytosomes was evaluated by reducing power method. The results showed that the Ashwagandha phytosome complex exhibited more antioxidant activity compared to the Ashwagandha extract. Hence it was concluded that Ashwagandha phytosomes serve as useful novel drug delivery system and provide more bioavailability than conventional formulations.

References

6